European Society for Blood and Marrow Transplantation

European Society for Blood and Marrow Transplantation is a research organisation in Leiden, Netherlands that has taken part in 8 EU-funded projects since 2010, receiving €3.6M in EU funding and leading 1 as coordinator.

EU funding received€3.6M
EU projects8
As coordinator1
Running now2
First EU project2010
Latest project2025
CountryNetherlands
EU registration (PIC)987932003
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are European Society for Blood and Marrow Transplantation's own share of each project, not the project's full budget.

  • EU4Health Programme (EU4H)€1.9M · 2 projects
  • Horizon Europe€1.5M · 2 projects
  • Horizon 2020€221k · 3 projects
  • FP7 (2007 to 2013)€25k · 1 project

Projects

8 EU-funded projects, newest first. European Society for Blood and Marrow Transplantation led 1 of them as coordinator. Each links to the official record.

  • EASYGENPartner

    EASY workflow integration for GENe therapy

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €381ktheir share
  • CERTAINTYPartner

    A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.1Mtheir share
  • EuroTraCTORCoordinator

    European Transplant and Cellular Therapy Online Registry

    EU4Health Programme (EU4H) · 2022–2025 · Project on the EU portal ↗

    €1.7Mtheir share
  • EGALiTEPartner

    European Group for Accreditation and Liaison of Blood-Tissues and Cells Establishments

    EU4Health Programme (EU4H) · 2022–2024 · Project on the EU portal ↗

    €250ktheir share
  • T2EVOLVEPartner

    Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

  • HARMONY PLUSPartner

    HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €121ktheir share
  • HARMONYPartner

    Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €100ktheir share
  • CELL-PIDPartner

    Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency

    FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗

    €25ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • big data
  • cells technologies
  • databases
  • ecosystems
  • employment
  • gene therapy
  • hematology
  • immunology
  • immunotherapy
  • innovation management
  • leukemia
  • oncology
  • pharmaceutical drugs
  • software development

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime